Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

1.2K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

906
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
906
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

24
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
24
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

26
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
26
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

30
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: gluten digestion in the stomach and duodenum by Aspergillus niger-derived enzyme - things to ponder. Authors' reply.

Alimentary pharmacology & therapeutics·2015
Same author

Editorial: enhancing gluten digestion in the stomach - a further help to minimise unintentional ingestion? Authors' reply.

Alimentary pharmacology & therapeutics·2015
Same author

Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.

Alimentary pharmacology & therapeutics·2015
Same author

Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis--authors' reply.

Alimentary pharmacology & therapeutics·2013
Same author

Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?

European journal of pain (London, England)·2013
Same author

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.

American journal of physiology. Gastrointestinal and liver physiology·2012
Same journal

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Gut·2026
Same journal

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Gut·2026
Same journal

USP20 promotes CD8<sup>+</sup> T cell exhaustion and impairs KRAS<sup>G12D</sup> inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

Gut·2026
Same journal

CTCF-rs705704-SUOX axis is important for the association between hypothyroidism and metabolic dysfunction-associated steatotic liver disease.

Gut·2026
Same journal

<i>Helicobacter pylori</i> infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trials.

Gut·2026
Same journal

Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

Gut·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis
08:10

Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: December 14, 2019

12.5K

Reversible gall bladder dysfunction in severe pancreatic insufficiency.

A A Masclee1, J B Jansen, F H Corstens

  • 1Department of Medicine, University Hospital Nijmegen, The Netherlands.

Gut
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Patients with pancreatic insufficiency have reduced gallbladder emptying due to impaired cholecystokinin (CCK) secretion. Supplementing pancreatic enzymes normalizes CCK release and gallbladder function, highlighting their crucial role.

More Related Videos

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
11:07

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: September 5, 2025

1.1K
Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy
10:09

Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy

Published on: March 17, 2026

414

Related Experiment Videos

Last Updated: May 4, 2026

Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis
08:10

Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: December 14, 2019

12.5K
Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
11:07

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: September 5, 2025

1.1K
Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy
10:09

Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy

Published on: March 17, 2026

414

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Digestive Physiology

Background:

  • Pancreatic insufficiency significantly impacts digestive processes.
  • Cholecystokinin (CCK) plays a key role in regulating gallbladder contraction.
  • The intestinal phase of digestion is critical for nutrient absorption and hormonal signaling.

Purpose of the Study:

  • To investigate the intestinal phase of CCK secretion and gallbladder contraction in patients with severe pancreatic insufficiency.
  • To determine the effect of pancreatic enzyme supplementation on CCK release and gallbladder function.
  • To elucidate the role of intra-intestinal pancreatic enzymes in CCK secretion and gallbladder emptying.

Main Methods:

  • Radioimmunoassay was used to measure plasma CCK concentrations.
  • Cholescintigraphy assessed gallbladder contraction.
  • Intraduodenal fat was administered with and without pancreatic enzymes to patients and healthy controls.

Main Results:

  • Patients with pancreatic insufficiency showed significantly reduced integrated plasma CCK secretion and gallbladder emptying in response to intraduodenal fat compared to healthy subjects.
  • Addition of pancreatic enzymes to intraduodenal fat normalized both plasma CCK levels and gallbladder emptying in patients.
  • Fasting plasma CCK concentrations were similar across all groups.

Conclusions:

  • Severe pancreatic insufficiency impairs gallbladder emptying due to a reduced intestinal CCK response.
  • Intra-intestinal pancreatic enzymes are essential for the normal intestinal phase of CCK secretion and gallbladder emptying.
  • Pancreatic enzyme supplementation can effectively normalize gallbladder function in patients with pancreatic insufficiency.